<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41816">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01845324</url>
  </required_header>
  <id_info>
    <org_study_id>0011-13</org_study_id>
    <nct_id>NCT01845324</nct_id>
  </id_info>
  <brief_title>Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers</brief_title>
  <official_title>Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators asume that the measurement of the fetal heart interventricular septum can
      serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus.
      The investigators will measure the septum width in patients with Diabetes and will correlate
      to standard measurements of the glucuse levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators will follow patients with Diabetes Mellitus - mainly
      gestational. the investigators will measure the width of the interventricular septum and
      correlate with conventional measures of blood glucose measurements in this population.

      The investigators will try to assess whether measurement of the septum can be an earlier and
      better predictor of glucose control in this population.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>width of fetal interventricula heart septum</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigator will assess the width of the fetal interventricular septum in patients with diabetes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>glucose control in patients with normal and abnormal interventricular septal width</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators will try to show that small interventricular septal width glucose correlates with good glucose control</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pregnancy</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetes Mellitus in pregnancy</arm_group_label>
    <description>Our cohort will include all consequtive women with Diabetes Mellitus atending our clinic</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All consequtive pregnant women with Diabetes Mellitus - Gestational and non Gestational
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consequtive pregnant women

          -  with Diabetes Mellitus - Gestational and non Gestational

        Exclusion Criteria:

        .No willing to participate.

          -  Suspected Heart anomaly
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alon Shrim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alon Shrim, MD</last_name>
    <phone>+972-4-6188224</phone>
    <email>alon.shrim@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alon Shrim, MD</last_name>
      <phone>+972-4-6188224</phone>
      <email>alon.shrim@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 30, 2013</lastchanged_date>
  <firstreceived_date>April 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
